1. Home
  2. MASK vs XGN Comparison

MASK vs XGN Comparison

Compare MASK & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MASK
  • XGN
  • Stock Information
  • Founded
  • MASK 2017
  • XGN 2002
  • Country
  • MASK China
  • XGN United States
  • Employees
  • MASK N/A
  • XGN N/A
  • Industry
  • MASK
  • XGN Medical Specialities
  • Sector
  • MASK
  • XGN Health Care
  • Exchange
  • MASK NYSE
  • XGN Nasdaq
  • Market Cap
  • MASK 37.7M
  • XGN 138.3M
  • IPO Year
  • MASK 2025
  • XGN 2019
  • Fundamental
  • Price
  • MASK $2.21
  • XGN $7.00
  • Analyst Decision
  • MASK
  • XGN Strong Buy
  • Analyst Count
  • MASK 0
  • XGN 2
  • Target Price
  • MASK N/A
  • XGN $7.50
  • AVG Volume (30 Days)
  • MASK 78.0K
  • XGN 237.8K
  • Earning Date
  • MASK 01-01-0001
  • XGN 08-04-2025
  • Dividend Yield
  • MASK N/A
  • XGN N/A
  • EPS Growth
  • MASK 12.16
  • XGN N/A
  • EPS
  • MASK 0.19
  • XGN N/A
  • Revenue
  • MASK $4,718,055.00
  • XGN $56,724,000.00
  • Revenue This Year
  • MASK N/A
  • XGN $19.39
  • Revenue Next Year
  • MASK N/A
  • XGN $13.27
  • P/E Ratio
  • MASK $11.48
  • XGN N/A
  • Revenue Growth
  • MASK 7.89
  • XGN 1.78
  • 52 Week Low
  • MASK $2.03
  • XGN $1.71
  • 52 Week High
  • MASK $4.19
  • XGN $7.95
  • Technical
  • Relative Strength Index (RSI)
  • MASK N/A
  • XGN 52.23
  • Support Level
  • MASK N/A
  • XGN $6.62
  • Resistance Level
  • MASK N/A
  • XGN $7.35
  • Average True Range (ATR)
  • MASK 0.00
  • XGN 0.48
  • MACD
  • MASK 0.00
  • XGN -0.10
  • Stochastic Oscillator
  • MASK 0.00
  • XGN 29.63

About MASK 3 E NETWORK TECHNOLOGY GROUP LTD

3 E Network Technology Group Ltd is a business-to-business (B2B) information technology (IT) business solutions provider. It focuses on integrated software and hardware solutions in the property management and exhibition services spaces and expanded software solutions offering to a variety of industries and sectors, including food establishments, real estate, exhibition & conferencing, and clean energy utilities. The business includes two main portfolios, namely the software development portfolio and exhibition and conference portfolio. Maximum revenue is generated from the software development portfolio.

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Share on Social Networks: